Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
64.10    -2.10 (-3.17%)
Bid:
63.90
Ask:
64.10
Spread: 0.20 (0.313%)
Market Cap: £566.28m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Director/PDMR Shareholding

17 Sep 2018 16:58

RNS Number : 0269B
IP Group PLC
17 September 2018
 

FOR RELEASE ON

17 September 2018

 

Re-issuing to correct the total beneficial interest.

 

 

IP Group plc - Director's share purchase

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, has been notified that on 17 September 2018, Alan Aubrey, Chief Executive, purchased a total of 16,110 Ordinary Shares of 2p each at a price of 124 pence per share.

 

Following this purchase, Alan Aubrey now has a total beneficial interest in 2,663,538 Ordinary Shares, representing 0.25% per cent of the Company's current issued share capital.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Alan Aubrey

2

Reason for the notification

a)

Position/status

 Chief Executive

 

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IP Group plc

b)

LEI

213800HG22UM138WFG43

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 2p each in IP Group plc

 

ISIN: GB00B128J450

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

 124 pence

16,110

 

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

17 September 2018

f)

Place of the transaction

London Stock Exchange, Main Market

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Greg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

 

For more information, please visit our website at www.ipgroupplc.com.

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGGUMABUPRGAM
Date   Source Headline
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20254:09 pmRNSHolding(s) in Company
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20254:45 pmRNSHolding(s) in Company
10th Nov 20256:02 pmRNSTransaction in Own Shares
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20254:51 pmRNSHolding(s) in Company
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20255:14 pmRNSHolding(s) in Company
4th Nov 20256:23 pmRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20255:25 pmRNSTotal Voting Rights
31st Oct 20255:19 pmRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20255:27 pmRNSTransaction in Own Shares
28th Oct 20256:06 pmRNSTransaction in Own Shares
28th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20255:31 pmRNSTransaction in Own Shares
24th Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20255:30 pmRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20255:59 pmRNSTransaction in Own Shares
16th Oct 20255:45 pmRNSTransaction in Own Shares
15th Oct 20255:20 pmRNSTransaction in Own Shares
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20256:18 pmRNSHolding(s) in Company
13th Oct 20257:00 amRNSPotential income from Metsera obesity drugs
10th Oct 20255:17 pmRNSTransaction in Own Shares
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNS-RPortfolio co Monolith to be acquired by CoreWeave
7th Oct 20255:21 pmRNSTransaction in Own Shares
6th Oct 20255:56 pmRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares
3rd Oct 20257:00 amRNSTransaction in Own Shares
1st Oct 20255:23 pmRNSTransaction in Own Shares
30th Sep 20256:05 pmRNSTotal Voting Rights
30th Sep 20256:03 pmRNSTransaction in Own Shares
30th Sep 20257:00 amRNSTransaction in Own Shares
29th Sep 20257:00 amRNS-RPortfolio co OXCCU completes £20.75m funding round
26th Sep 20255:36 pmRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20255:36 pmRNSTransaction in Own Shares
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
19th Sep 20254:55 pmRNSTransaction in Own Shares
18th Sep 20255:24 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.